Warning: This security is no longer trading.
UCB Completes the Acquisition of Ra Pharmaceuticals
Ra Pharmaceuticals, Inc. (RARX): Price and Financial Metrics
RARX Price/Volume Stats
| Current price | $48.00 | 52-week high | $48.02 |
| Prev. close | $48.01 | 52-week low | $19.64 |
| Day low | $47.98 | Volume | 3,864,600 |
| Day high | $48.01 | Avg. volume | 1,158,500 |
| 50-day MA | $46.43 | Dividend yield | N/A |
| 200-day MA | $39.47 | Market Cap | 2.27B |
RARX Stock Price Chart Interactive Chart >
Ra Pharmaceuticals, Inc. (RARX) Company Bio
Ra Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of novel therapeutics for the treatment of diseases caused by excessive or uncontrolled activation of the complement system. Its peptide chemistry platform delivers enables the production of synthetic macrocyclic peptides that combine the diversity and specificity of antibodies with the pharmacological properties of small molecules. The company was founded in 2008 and is based in Cambridge, Massachusetts.
RARX Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
RARX Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | 0.00% |